UBS AM’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.73K Buy
+695
New +$1.82K ﹤0.01% 4063

Other funds holding OVID

UBS AM's OVID Position: Q3 2026 in Review

UBS AM opened a new position in Ovid Therapeutics (OVID) in Q3 2026: 695 shares worth $1.73K. The stake represents ﹤0.01% of the portfolio and ranks #4063 among its holdings.

107 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • UBS AM held 695 shares of Ovid Therapeutics worth $1.73K as of Q3 2026.
  • Ovid Therapeutics was a new UBS AM position in Q3 2026.
  • Ovid Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4063 holding.
  • 107 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.